Hedge Fund Filings: After-Market 13D Watch
2) James Roumell and Roumell Asset Management, whom we track, owns shares of Transcept Pharmaceuticals Inc (NASDAQ:TSPT).
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Springbok Capital Gavin Saitowitz And Cisco J. Del Valle | 0 | $0 | 0% | |
2. | GAMCO Investors Mario Gabelli | 0 | $0 | 0% | |
3. | Havens Advisors Nancy Havens-Hasty | 0 | $0 | 0% | |
4. | Alpine Associates Robert Emil Zoellner | 0 | $0 | 0% | |
5. | D E Shaw D. E. Shaw | 0 | $0 | 0% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$12.98 | 4,400 | Director | 41,000 | 2013-05-13 | Filing | |
$12.64 | 5,600 | Director | 36,600 | 2013-05-09 | Filing | |
$14.93 | 2,000 | Director | 9,000 | 2013-02-15 | Filing | |
$16.18 | 3,000 | Director | 7,000 | 2012-11-09 | Filing | |
$15.74 | 6,000 | Director | 31,000 | 2012-06-15 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$16.27 | 3,800 | Officer, Director | 967,473 | 2013-03-05 | Filing | |
$15.30 | 10,000 | Officer | 75,000 | 2013-02-21 | Filing | |
$18.05 | 1,500 | Officer, Director | 882,293 | 2012-12-07 | Filing | |
$18.00 | 6,600 | Officer, Director | 883,793 | 2012-12-06 | Filing | |
$19.39 | 10,000 | Officer | 65,000 | 2012-11-29 | Filing |